search.noResults

search.searching

saml.title
dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
SKIN CARE Control ■ 0.1% Goji stem cell extract ■


1000 800 600 400 200 0


Control CRCT1 LCE2B LOR


Figure 3: Increased expression of genes important for skin barrier formation


in phosphate buffered saline (PBS) solution and immediately frozen at -80°C. Total RNA was extracted from the cells and the expression of extracellular matrix genes was then assessed with RT-qPCR using the LightCycler System (Roche).


Clinical anti-aging study In a randomized, placebo-controlled clinical study, 23 Caucasian women aged between 41 and 69 years (mean age: 56 years) who displayed signs of photoaging applied either a cream with 0.4% goji stem cell active (INCI: Lycium Barbarum Callus Culture Extract (and) Isomalt (and) Lecithin (and) Aqua / Water) on one half of the face and one forearm and the corresponding placebo on the other half of the face and the other forearm, twice daily for a period of 56 days. The wrinkle depth was measured using PRIMOS lite (Canfield). The density of the


A BEFORE AFTER 28 DAYS


Control ■ 0.1% Goji stem cell extract ■ 2


1.5 1 100 0.5 0


Total protein quantification


Enzyme activity quantification


Figure 4: Increased exosome production in mesenchymal stem cells


skin (epidermis + dermis) was determined by ultrasonic measurements in triplicates using DermaScan C (Cortex) which counts the number of low-echogenic pixels corresponding to low- density areas on a 2-D portion of epidermis and dermis. The lower the number of dark pixels the higher the skin density.


Clinical face contour study In a randomized, placebo-controlled clinical study, sixty-seven Caucasian women aged between 39 and 70 years (average age 57 years) with sagging facial skin were split into two groups. One group applied a cream with 0.4% goji stem cell active and the other group applied the corresponding placebo cream on the entire face and neck twice daily for 28 days. The facial sagging and oval face shape was


determined by measuring the size of the neck/ submandibular triangle area by image analysis of the pictures of the volunteers’ faces that were


B BEFORE


Figure 5: Improved cell-cell communication assessed by gene expression analysis in fibroblasts treated with conditioned medium from mesenchymal stem cells (MSCs)


taken with Visioface 1000 D (Courage + Khazaka). For the image analysis, a straight line was drawn vertically through the middle of the chin. On either side of the face, vertical parallel


lines were drawn to intersect at the start of the jawline/sagging skin. The points of the jawline intersection were then connected with the middle of the chin. The area below the drawn V lines was determined. A reduction of this area would suggest a reduction in facial sagging and an improved V-shape of the face.


Clinical breast lifting study The effect of goji stem cell active on breast sagging was tested in a randomized, placebo- controlled clinical study with 44 women aged between 18 and 44 years (mean age: 29.4 years) with breast sizes 80B, 85A, 90A, and 90B. The women were split into two groups of 22


AFTER 56 DAYS 0 * 200


45


Conditioned medium from untreated MSCs ■ Condition medium from MSCs treated ■


with 1% Goji stem cell extract *p<0.05 versus control 300


BEFORE


AFTER 56 DAYS


Figure 6: Improved skin density and wrinkle appearance. A: Subepidermal low-echogenic bands (SLEB) were reduced after 28 days of treatment with goji stem cell active. B: Wrinkles appearance in the crow’s feet area was visibly improved after 56 days of treatment with goji stem cell active


www.personalcaremagazine.com January 2025 PERSONAL CARE


Gene expression changes compared to control (=100) in %


Increase in exosome levels normalised to control (=1)


Change in gene expression compared to control (=100) in %


Control COL3A1


COL16A1 Elastin PLOD1 LOX


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76